[1] YuJJ, 2015.Use of corticosteroids during acute phase of Kawasaki disease,World J Clin Pediatr 4 135 -142
[2] GolshevskyD,CheungM,BurgnerD., 2013.Kawasaki disease: the importance of prompt recognition and early referral,Australian Fam Physician 42 473 -6
[3] JamiesonN,Singh-GrewalD, 2013.Kawasaki disease: a clinician's update,Int J Pediatr 645391 -
[4] RowleyAH, 2011.Kawasaki disease: novel insights into etiology and genetic susceptibility,Ann RevMed 62 69 -77
[5] ChoJH,HanMY,ChaSH,JungJH,YoonKL, 2014.Genetic polymorphism of SMAD5 is associated with kawasaki disease,Pediatr Cardiol 35 601 -7
[6] Sánchez-ManubensJ,BouJ,AntonJ, 2014.Diagnosis and classification of Kawasaki disease,J Autoimmun 48 113 -7
[7] NewburgerJW,TakahashiM,BeiserAS,BurnsJC,BastianJ,ChungKJ, 1991.A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute kawasaki syndrome,New Engl J Med 324 1633 -9
[8] DragoF,JavorS,CiccareseG,CozzaniE,ParodiA., 2015.A case of complete adult-onset Kawasaki disease: A review of pathogenesis and classification,Dermatology 231 5 -8
[9] KontopoulouT,KontopoulosDG,VaidakisE,MousoulisGP, 2015.Adult Kawasaki disease in a European patient: a case report and review of the literature,J Med Case Reports 9 75 -
[10] BayersS,ShulmanST,PallerAS, 2013.Kawasaki disease: Part II. Complications and treatment,J Am Acad Dermatol 69 513e1 -e8
[11] WolffAE,HansenKE,ZakowskiL, 2007.Acute kawasaki disease: not just for kids,J Gen Intern Med 22 681 -4
[12] Berdej-SzczotE,Firek-PedrasM,SzydlowskiL,KrzystolikLadzinskaJ,KlimekK,Malecka-TenderaE., 2013.Analysis of risk factors and prospective evaluation of cardiovascular complications of Kawasaki disease in children: a single centre study,Kardiologia Polska. Polish Heart J 71 1279 -86
[13] GaleottiC,BayryJ,Kone-PautI,SrinivasV.,Kaveri, 2010.Kawasaki disease: Aethiopatogenesis and therapeutic utility of intravenous immunoglobulin,Autoimmun Rev 9 441 -8
[14] NewburgerJW,TakahashiM,GerberMA,GewitzMH,TaniLY,JaneC, 2004.Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association,Pediatrics 114 1708 -33
[15] NewburgerJW,TakahashiM,GerberMA, 2004.Diagnosis, treatment, and long-term management of Kawasaki disease,Circulation 27 2747 -71
[16] NewburgerJW,TakahashiM,BurnsJC., 1986.The treatment of Kawasaki Syndrome with intravenous gamma globulin,New Engl J Med 315 341 -7
[17] KorenG,RoseV,LaviS,RoweR, 1985.Probable efficacy of highdose salicylates in reducing coronary involvement in Kawasaki disease,JAMA 254 767 -9
[18] SèveP,StankovicK,SmailA,DurandDV,MarchandG,BroussolleC, 2005.Adult Kawasaki disease: report of two cases and literature review,Semin Arthritis Rheum 34 785 -92
[19] JacksonJL,KunkelMR,LibowL,GatesRH, 1994.Adult Kawasaki disease: report of two cases treated with intravenous gamma globulin,Arch Intern Med 154 1398 -405
[20] RozoJC,JefferiesJL,EidemBW,CookPJ, 2004.Kawasaki disease in the adult: a case report and review of the literature,Texas Heart Inst J 31 160 -4
[21] BayrouO,PhlippoteauC,ArtigouC,HaddadT,LeynadierF.,Adult, 1993.Kawasaki syndrome associated with HIV infection and anti-cardiolipin antibodies,J Am Acad Dermatol 29 663 -4
[22] FasonJT,FryYW,SmithD, 2004.Kawasaki disease in a postpartum patient,J Natl Med Assoc 96 1499 -502